The global insulin pump market, valued at USD 4.86 billion in 2022, is poised for substantial growth, projected to reach USD 15.5 billion by 2032 with a CAGR of 12.8% during 2023-2032. This growth is driven by several factors, including the rising prevalence of diabetes and the increasing preference for insulin pump.
Insulin pumps are now more readily available than ever. A medical company has plugged the market gap for wearable insulin pumps. Insulet Corporation has recently announced that its Omnipod 5 tubeless Automated Insulin Delivery (AID) System, made for people with Type 1 diabetes, is now available across the US, per Health Insider.